Bristol Myers Squibb will become the 12th drugmaker to restrict 340B discounts after it signaled its intent to limit such discounts for safety net hospitals’ contract pharmacies, according to a recent letter the company sent out to hospitals.
Bristol Myers Squibb will become the 12th drugmaker to restrict 340B discounts after it signaled its intent to limit such discounts for safety net hospitals’ contract pharmacies, according to a recent letter the company sent out to hospitals.